Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business
  • interests

Trending on Bing

Feds search Trump home
Dies filming show
Forgot to hire staff
‘Spoils spontaneity’
Felony burglary charge
Goes after new owners
11-year-old scammed
Feds to seize plane
Drafted resignation
Succumbs to cancer
Russian losses mount
Autopsy released
Navy recovers jet
Trump ally testifying
Next Professor X?
143 cocks euthanized
Seeks testimony delay
Wrongful death lawsuit
Repeating conspiracies
Taurasi out for season
$1B in arms to Ukraine
Driverless taxis OK'd
Hulu ‘stole my story’
Chiefs sign Dickerson
Cleared for deliveries
Tours Ky. flood damage
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
9,640 results
BioNTech, Pfizer could deliver Omicron-adapted COVID-19 vaccines in October
BioNTech and Pfizer announced trials this month for their adapted COVID-19 vaccines, to fight faster-spreading Omicron ...
UPI.com on MSN.com
10h
Vaccine Targeting Fast-Spreading Omicron Subvariants Could Be Ready For Fall As Pfizer, BioNTech Announce Trials
BioNTech and its U.S. partner Pfizer have already begun manufacturing Covid-19 boosters that are adapted for multiple Omicron ...
Forbes on MSN.com
16h
COVID-19 vaccine maker BioNTech expects updated omicron-specific shots by October
BioNTech, with its partner Pfizer, expects to begin deliveries of two omicron-adapted vaccines as soon as October in time for ...
Washington Examiner on MSN.com
6h
Why Pfizer and BioNTech Are Beating Moderna in the Omicron Booster Market
Pfizer and BioNTech received a larger initial order from the U.S. government than Moderna did for omicron boosters. The U.S.
The Motley Fool on MSN.com
6d
Pfizer and BioNTech say updated Covid-19 boosters show increased immune response against Omicron variant
Two Pfizer and BioNTech Covid-19 vaccine boosters updated to target the Omicron variant show a substantially higher immune response than the current Covid-19 vaccine, the companies said Saturday.
KESQ News1mon
Pfizer, BioNTech to study 'bivalent' booster as FDA weighs approach
The small-scale study is part of the companies’ efforts to update their vaccine in time for a potential fall vaccination ...
BioPharma Dive
12d
UPDATE 2-BioNTech expects Omicron-adapted vaccine deliveries as soon as October
BioNTech expects to begin deliveries of two Omicron-adapted vaccines as soon as October, which will help spur demand in the fourth quarter, the German biotech firm said on Monday as it reaffirmed its ...
YAHOO!Finance
18h
Pfizer, BioNTech say updated vaccines offer ‘substantially higher immune response’ against omicron
Pharmaceutical and biotechnology companies Pfizer and BioNTech announced Saturday that updated versions of their ... Studies “found that a booster dose of both Omicron-adapted vaccine candidates ...
MSN1mon
Pfizer/BioNTech say Omicron-based COVID shots improve response vs that variant
NEW YORK — Pfizer Inc and BioNTech SE said on Saturday that a booster dose of updated versions of their COVID-19 vaccine, modified specifically to combat the Omicron coronavirus variant, generated a ...
Financial Post1mon
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design
Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) today announced that the companies have initiated a randomized, active-controlled, observer-blind Phase 2 study to ...
Benzinga.com
12d
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron
Omicron-adapted monovalent candidate given as a fourth booster dose elicited a 13.5 and 19.6-fold increase in neutralizing geometric titers against Omicron BA.1 at 30 µg and 60 µg dose levels; ...
Yahoo News Singapore1mon
© 2022 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback